Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECNIDAZOLE for Bacterial vulvovaginitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where SECNIDAZOLE was used for Bacterial vulvovaginitis.

Most Reported Side Effects for SECNIDAZOLE

Side Effect Reports % Deaths Hosp.
Vomiting 77 31.4% 0 5
Nausea 50 20.4% 0 1
Drug ineffective 28 11.4% 1 1
Wrong technique in product usage process 22 9.0% 0 0
Diarrhoea 21 8.6% 0 1
Product taste abnormal 21 8.6% 0 0
Headache 19 7.8% 0 0
Dysgeusia 18 7.4% 0 0
Abdominal pain 16 6.5% 0 3
No adverse event 13 5.3% 0 0
Malaise 12 4.9% 0 0
Abdominal discomfort 10 4.1% 0 0
Bacterial vaginosis 9 3.7% 0 0
Chromaturia 9 3.7% 0 0
Abdominal pain upper 8 3.3% 0 0

Other Indications for SECNIDAZOLE

Bacterial vaginosis (128) Product used for unknown indication (86) Vaginal infection (8)

Other Drugs Used for Bacterial vulvovaginitis

METRONIDAZOLE (23) CLINDAMYCIN (13) CIPROFLOXACIN (5) FLUCONAZOLE (5)

Related Pages

SECNIDAZOLE Full Profile All Bacterial vulvovaginitis Drugs SECNIDAZOLE Demographics SECNIDAZOLE Timeline